Virginia Retirement Systems Et Al Arrowhead Pharmaceuticals, Inc. Transaction History
Virginia Retirement Systems Et Al
- $15 Billion
- Q3 2025
A detailed history of Virginia Retirement Systems Et Al transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 15,000 shares of ARWR stock, worth $635,850. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$635,850% of portfolio
0.0%Shares
16 transactions
Others Institutions Holding ARWR
# of Institutions
328Shares Held
99.7MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$665 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$658 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$449 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$270 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$222 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.49B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...